Skip to main content
C

China Resources Boya Bio-pharmaceutical Group Co., Ltd — Investor Relations & Filings

Ticker · 300294 LEI · 836800D4KUVERU6C7D85 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,338 across all filing types
Latest filing 2026-04-24 M&A Activity
Country CN China
Listing Shenzhen Stock Exchange 300294

About China Resources Boya Bio-pharmaceutical Group Co., Ltd

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of blood products and plasma-derived medicinal products. The company operates an integrated value chain encompassing plasma collection, fractionation, and pharmaceutical manufacturing. Its core product portfolio includes human albumin, intravenous immunoglobulin (IVIG), and various coagulation factors such as Factor VIII and prothrombin complex. The organization focuses on therapeutic areas including immunology, hematology, and critical care. By leveraging advanced purification technologies and a network of plasma donation centers, the company provides essential treatments for rare diseases and emergency medical needs. Its operations are characterized by rigorous quality control standards and a commitment to innovation in biopharmaceutical processing and therapeutic development.

Recent filings

Filing Released Lang Actions
公司关于转让南京新百药业股份有限公司100%股权暨关联交易的公告
M&A Activity Classification · 1% confidence The document is a detailed announcement of a related‐party transaction disposing of 100% equity of a subsidiary (南京新百药业有限公司), including transaction parties, pricing policy, agreement terms, internal approvals, auditor and appraiser opinions, and regulatory compliance. It is not an annual report, earnings release, or simple publication notice but a specific M&A transaction disclosure. This fits the M&A Activity category (TAR).
2026-04-24 Chinese
公司关于会计政策变更的公告
Regulatory Filings Classification · 1% confidence The document is an official announcement by a listed company regarding a change in accounting policy driven by a new Ministry of Finance interpretation, referencing exchange listing rules and stating no board or shareholder approval is required. It is not a full financial report, earnings release, or presentation but a regulatory disclosure of policy change. It therefore falls under general regulatory filings (RNS).
2026-04-24 Chinese
南京新百药业有限公司专项审计报告
Audit Report / Information Classification · 1% confidence The document begins with “审计报告” and includes an auditor’s opinion, basis for the opinion, management responsibilities, auditor responsibilities, and a full set of financial statements with notes. It is a standalone audit report (with report number and signatures) and not an announcement or summary. Therefore, it matches the Audit Report / Information category.
2026-04-24 Chinese
关于华润博雅生物制药集团股份有限公司向特定对象发行股票项目持续督导变更保荐代表人的说明
Regulatory Filings Classification · 1% confidence The document comprises three notices by CITIC Securities to the Shenzhen Stock Exchange and China Securities Regulatory Commission regarding a change in the sponsor representative for an ongoing specific-object share issuance project. It is a regulatory announcement about process personnel assignment rather than a financial report, AGM materials, dividend notice, or management change at the issuer. This type of generic regulatory filing that doesn’t fit other categories falls under ‘Regulatory Filings’ (RNS).
2026-04-21 Chinese
公司关于更换持续督导保荐代表人的公告
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (“公告”) reporting the replacement of a continuous supervision sponsor representative for an equity fundraising project. It does not present financial results, governance rules, or financing terms, nor is it a formal report (e.g., 10-K, interim report) or management change at the board/executive level. It therefore falls into the fallback category for miscellaneous regulatory filings.
2026-04-21 Chinese
2025年年度股东会决议公告
Regulatory Filings
2026-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.